In the fight against fatty liver disease, researchers are looking for any and all possible solutions.
But to combat the disease, which is also known as metabolic dysfunction-associated steatotic liver disease, or MASLD, scientists must first understand how the liver metabolizes fat. MASLD is on the rise in the U.S., now affecting nearly 40% of adults. The condition occurs when the body deposits extra fat in the liver, leading to inflammation, fibrosis and, in some cases, permanent liver damage or liver cancer.
A new study by researchers at Yale School of Medicine (YSM), published August 27, 2024 in the journal Cell Metabolism, finds that people with MASLD burn fat in their livers at the same rate as people without the disease. The study, whose senior author is Gerald Shulman, M.D., Ph.D., George R. Cowgill Professor of Medicine (Endocrinology) and Professor of Cellular and Molecular Physiology at YSM, appears to settle this question, which has been in dispute in the field…
Read the full article here.
